Clinical Investigation of the AcrySof IQ Vivity Extended Vision Intraocular Lens (IOL)

NACompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

November 18, 2019

Primary Completion Date

May 3, 2021

Study Completion Date

July 22, 2021

Conditions
Aphakia
Interventions
DEVICE

VIVITY

Extended vision intraocular lens intended for primary implantation for the visual correction of aphakia in adult patients with less than 1.00 diopter of preoperative corneal astigmatism in whom a cataractous lens has been removed by extracapsular cataract extraction

DEVICE

SYMFONY

Extended range of vision intraocular lens indicated for primary implantation for the visual correction of aphakia in adult patients with less than 1.00 diopter of pre-existing corneal astigmatism in whom a cataractous lens has been removed

DEVICE

AT LARA

Extended depth of focus intraocular lens indicated for implantation for the visual correction of aphakia in patients with and without presbyopia in whom a cataractous lens has been removed by extracapsular cataract extraction

PROCEDURE

Cataract surgery

Cataract removal by routine small incision surgery

Trial Locations (12)

1050

Alcon Investigator 8056, Auckland

2067

Alcon Investigator 6667, Sydney

2150

Alcon Investigator 7678, Sydney

2290

Alcon Investigator 8047, Charlestown

3011

Alcon Investigator 7813, Footscray

3040

Alcon Investigator 8010, Essendon

3931

Alcon Investigator 1702, Mornington

5063

Alcon Investigator 8052, Eastwood

6011

Alcon Investigator 3656, Wellington

6150

Alcon Investigator 8051, Murdoch

7000

Alcon Investigator 7130, Hobart

Unknown

Alcon Investigator 8050, Auckland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT04098367 - Clinical Investigation of the AcrySof IQ Vivity Extended Vision Intraocular Lens (IOL) | Biotech Hunter | Biotech Hunter